Cerebral amyloid angiopathy is a pathogenic lesion in Alzheimer's disease due to a novel presenilin 1 mutation

Brain. 2001 Dec;124(Pt 12):2383-92. doi: 10.1093/brain/124.12.2383.

Abstract

The dense-cored plaques are considered the pathogenic type of amyloid deposition in Alzheimer's disease brains because of their predominant association with dystrophic neurites. Nevertheless, in > 90% of cases of Alzheimer's disease amyloid is also deposited in cerebral blood vessel walls (congophilic amyloid angiopathy; CAA) but its role in Alzheimer's disease pathogenesis remains enigmatic. Here, we report a family (family GB) in which early-onset Alzheimer's disease was caused by a novel presenilin 1 mutation (L282V). This was unusually severe CAA reminiscent of the Flemish amyloid precursor protein (A692G) mutation we reported previously, which causes Alzheimer's disease and/or cerebral haemorrhages. In family GB, however, the disease presented as typical progressive Alzheimer's disease in the absence of strokes or stroke-like episodes. Similarly, neuroimaging studies and neuropathological examination favoured a degenerative over a vascular dementia. Interestingly, an immunohistochemical study revealed that, similar to causing dense-cored amyloid plaques, CAA also appeared capable of instigating a strong local dystrophic and inflammatory reaction. This was suggested by the observed neuronal loss, the presence of tau- and ubiquitin-positive neurites, micro- and astrogliosis, and complement activation. Together, these data suggest that, like the dense-cored neuritic plaques, CAA might represent a pathogenic lesion that contributes significantly to the progressive neurodegeneration that occurs in Alzheimer's disease.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Alzheimer Disease / diagnostic imaging
  • Alzheimer Disease / genetics*
  • Alzheimer Disease / pathology*
  • Amyloid beta-Peptides / analysis
  • Amyloid beta-Peptides / immunology
  • Amyloid beta-Peptides / metabolism
  • Cell Line
  • Cerebral Amyloid Angiopathy, Familial / diagnostic imaging
  • Cerebral Amyloid Angiopathy, Familial / genetics*
  • Cerebral Amyloid Angiopathy, Familial / pathology*
  • Family Health
  • Fatal Outcome
  • Female
  • Frontal Lobe / chemistry
  • Frontal Lobe / pathology
  • Genotype
  • Humans
  • Immunohistochemistry
  • Kidney / cytology
  • Male
  • Membrane Proteins / genetics*
  • Middle Aged
  • Mutagenesis, Site-Directed
  • Mutation
  • Pedigree
  • Polymorphism, Restriction Fragment Length
  • Presenilin-1
  • Radionuclide Imaging

Substances

  • Amyloid beta-Peptides
  • Membrane Proteins
  • PSEN1 protein, human
  • Presenilin-1